The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Metabolic and haemodynamic perturbations and their interaction drive the development of
diabetic kidney disease (DKD) and its progression towards end stage renal disease (ESRD) …

This is an opportune time to publish the first KDIGO 2020 Clinical Practice Guideline for
Diabetes Management in Chronic Kidney Disease (CKD). Worldwide, the estimated number …

The original KDIGO Clinical Practice Guideline for the Management of Blood Pressure in
Chronic Kidney Disease in the chronic kidney disease (CKD) population not receiving …

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

Background: Diabetic kidney disease (DKD) is the most common cause of the end-stage
renal disease (ESRD). Regardless of intensive treatments with hyperglycemic control, blood …

Chronic kidney disease is a common disorder and its prevalence is increasing worldwide.
Early diagnosis on the basis of presence of proteinuria or reduced estimated glomerular …

Objective: To determine whether tight control of blood pressure with either a β blocker or an
angiotensin converting enzyme inhibitor has a specific advantage or disadvantage in …

In the not-so-distant past, type 2 diabetes mellitus was thought to be a relatively benign
condition, at least in the elderly, with relatively little effect on life expectancy or renal function …

Background Diabetic retinopathy is a common complication of diabetes and a leading cause
of visual impairment and blindness. Research has established the importance of blood …